Literature DB >> 11298557

An extremely severe case of cutaneous calcinosis with juvenile dermatomyositis, and successful treatment with diltiazem.

Y Ichiki1, T Akiyama, N Shimozawa, Y Suzuki, N Kondo, Y Kitajima.   

Abstract

A case of cutaneous calcinosis associated with juvenile dermatomyositis is described. The patient was a 3-year-old girl who had been diagnosed as having dermatomyositis at age 1 year. She was treated with prednisolone, but developed multiple calcified nodules in the subcutaneous tissues and intermuscular fascia. These nodules gradually increased in size despite continual therapy with steroids and aluminium hydroxide. Treatment with diltiazem completely suppressed the development of calcinosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11298557     DOI: 10.1046/j.1365-2133.2001.04153.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  13 in total

1.  An Update on the Treatment of the Cutaneous Manifestations of Systemic Sclerosis: The Dermatologist's Point of View.

Authors:  Magalys Vitiello; Adriana Abuchar; Néstor Santana; Luis Dehesa; Francisco A Kerdel
Journal:  J Clin Aesthet Dermatol       Date:  2012-07

Review 2.  Treatment of inflammatory myopathies.

Authors:  A C Cordeiro; D A Isenberg
Journal:  Postgrad Med J       Date:  2006-07       Impact factor: 2.401

Review 3.  Juvenile dermatomyositis: recognition and treatment.

Authors:  Ann M Reed; Maricarmen Lopez
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 4.  Treatment of Calcinosis in Juvenile Dermatomyositis.

Authors:  Ovgu Kul Cinar; Charalampia Papadopoulou; Clarissa A Pilkington
Journal:  Curr Rheumatol Rep       Date:  2021-02-08       Impact factor: 4.592

5.  Electric shock wave lithotripsy (ESWL) as a pain control measure in dermatomyositis with calcinosis cutis-old method, new discovery.

Authors:  Alice Y K Chan; Edmund Li
Journal:  Clin Rheumatol       Date:  2004-11-24       Impact factor: 2.980

Review 6.  Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis?

Authors:  Antonia Valenzuela; Lorinda Chung
Journal:  J Scleroderma Relat Disord       Date:  2021-10-28

Review 7.  Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis.

Authors:  Ilana Chefetz; Eli Sprecher
Journal:  Biochim Biophys Acta       Date:  2008-10-25

Review 8.  Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management.

Authors:  Hobart W Walling; Pedram Gerami; Richard D Sontheimer
Journal:  Paediatr Drugs       Date:  2010       Impact factor: 3.022

9.  Hyperphosphatemic familial tumoral calcinosis: odontostomatologic management and pathological features.

Authors:  Gianfranco Favia; Maria Grazia Lacaita; Luisa Limongelli; Angela Tempesta; Nicola Laforgia; Angela Pia Cazzolla; Eugenio Maiorano
Journal:  Am J Case Rep       Date:  2014-12-24

Review 10.  Tumoral calcinosis: new insights for the rheumatologist into a familial crystal deposition disease.

Authors:  Eli Sprecher
Journal:  Curr Rheumatol Rep       Date:  2007-06       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.